FDA Unveils New Regulatory Science Strategy
August 17, 2011
FDA Unveils New Regulatory Science Strategy
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- No Last-Minute Deal Likely, Sequester Set to Take Effect
March 1, 2013 / GenomeWeb Daily News - Q&A: CDRH's Gutierrez, Mansfield Discuss Ongoing Regulatory Efforts in Personalized Medicine
January 2, 2013 / Pharmacogenomics Reporter - Seeking 510(k) Clearance for Genomic Testing Service, 23andMe Maintains Direct-to-Consumer Ethos
August 1, 2012 / Pharmacogenomics Reporter - FDA Issues Draft Guidance on Pre-Submission Program to Help Device Makers Gain Early Agency Feedback
July 18, 2012 / Pharmacogenomics Reporter - Texas Congressman Drafts Bill to Keep Lab Test Oversight out of 'FDA's Lap,' Expand Authority of CMS
October 19, 2011 / Pharmacogenomics Reporter